Search results

Blog

Drug Development Timelines: How Health Canada’s 30-Day Regulatory Review Process Could Provide an Advantage

May 3, 2023

The EMA recently updated their clinical trial application process. Discover how Health Canada's CTA process compares.
Blog

Five Reasons to Choose Canada for Your Clinical Trials—From the Webinar Demystifying the Conduct of Clinical Trials in Canada

Mar 7, 2023

Five advantages of conducting clinical trials in Canada. Read this overview to find out more.
- Clinical Trials
- Regulatory Affairs
Blog

Five Facts About Psychedelics for Mental Health

May 16, 2022
- Clinical Trials
- Regulatory Affairs
Blog

Three Key Advantages of Conducting Early-Phase Clinical Trials in North America: An Overview of the Webinar “A Hop Across the Pond”

Mar 31, 2022
- Regulatory Affairs
- Clinical Trials
Blog

Psychedelics — Regulatory Environment Challenges

Nov 29, 2021
Blog

The Next Trip: Developing the Second Generation of Psychedelics and Their Analogs for Targeted Medical Use

Nov 1, 2021
- Regulatory Affairs
- Clinical Trials
Blog

2020 Year in Review

Dec 14, 2020

2020 has been quite a year! Each year, we strive to provide you with a more innovative, simplified, and seamless early phase drug development journey. And the past 12 months have been no exception.